Home › Funds › Lion Point Capital, LP › QURE
Lion Point Capital, LP position in QURE
UNIQURE NV · Health Care
Lion Point Capital, LP reported holding 14,700 shares of QURE (UNIQURE NV) in its Q2 2026 13F filing — a position valued at US$677K, representing 3.24% of its reported portfolio and ranking #12 among its reported holdings. Lion Point Capital, LP has disclosed QURE holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Lion Point Capital, LP's QURE position evolved
Lion Point Capital, LP first disclosed a stake in QURE in Q4 2025 at 14,700 shares (US$352K). The position peaked in Q2 2026 at 14,700 shares, worth US$677K. Across 3 filings, Lion Point Capital, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 14,700 shares valued at US$677K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 14.70K | $351.77K | New |
| Q1 2026 | 14.70K | $240.34K | Hold |
| Q2 2026 | 14.70K | $677.08K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About QURE and 13F data
QURE (UNIQURE NV) is a Health Care company. 65 other funds we track also report a position in QURE — the largest reported positions include Avoro Capital Advisors LLC (US$309.9M), RTW INVESTMENTS, LP (US$181.5M), ORBIMED ADVISORS LLC (US$83.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding QURE
- Avoro Capital Advisors LLC 6.73M sh · $309.88M · Q2 2026
- RTW INVESTMENTS, LP 3.94M sh · $181.55M · Q2 2026
- ORBIMED ADVISORS LLC 1.81M sh · $83.25M · Q2 2026
- Boxer Capital Management, LLC 1.50M sh · $69.24M · Q2 2026
- MAK CAPITAL ONE LLC 1.23M sh · $56.75M · Q2 2026
- MPM BioImpact LLC 1.23M sh · $56.46M · Q2 2026
- Vestal Point Capital, LP 935.00K sh · $43.07M · Q2 2026
- Maverick Capital 925.38K sh · $42.62M · Q2 2026
- MAVERICK CAPITAL LTD 925.38K sh · $42.62M · Q2 2026
- Integral Health Asset Management, LLC 900.00K sh · $41.45M · Q2 2026
- Longaeva Partners L.P. 804.59K sh · $37.06M · Q2 2026
- Two Seas Capital LP 1.32M sh · $31.99M · Q3 2026
More on Lion Point Capital, LP
FAQ
How long has Lion Point Capital, LP held QURE?
Lion Point Capital, LP has disclosed QURE holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Lion Point Capital, LP's current position in QURE?
As of Q2 2026, Lion Point Capital, LP holds 14.70K shares of QURE (UNIQURE NV), valued at $677.08K, representing 3.24% of its reported portfolio and ranking #12.
Has Lion Point Capital, LP been buying or selling QURE?
In the latest 13F filing (Q2 2026), Lion Point Capital, LP held unchanged its position in QURE. The position peaked in Q2 2026 at 14.70K shares.
Which other funds hold QURE?
Other major institutional holders of QURE include Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, ORBIMED ADVISORS LLC, among 65 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.